DNA adduct formation by 2,6-dimethyl-, 3,5-dimethyl-, and 3-ethylaniline in vivo in mice

Chemical Research in Toxicology

Volumn 19, Issue 8, 2006, Pages 1086-1090

  Skipper, Paul L ^a,c   Trudel, Laura J ^a   Kensler, Thomas W ^b   Groopman, John D ^b   Egner, Patricia A ^b   Liberman, Rosa G ^a   Wogan, Gerald N ^a   Tannenbaum, Steven R ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b The Johns Hopkins University   (United States)

^c Building 56 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,6 DIMETHYLANILINE; 3,5 DIMETHYLANILINE; ANILINE DERIVATIVE; AROMATIC AMINE; DNA; ETHYLANILINE; NUCLEOTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CANCER; DNA ADDUCT; DNA BINDING; GENOTOXICITY; HAMSTER; IN VIVO STUDY; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN;

ANILINE COMPOUNDS; ANIMALS; DNA; DNA ADDUCTS; LIVER; MALE; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; STRUCTURE-ACTIVITY RELATIONSHIP; URINARY BLADDER;

ANIMALIA;

EID: 33748648174     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx060082q     Document Type: Article

References (16)

1. Woo, Y. T., and Lai, D. Y. (2001) Aromatic amino and nitro-amino compounds and their halogenated derivatives. In Patty's Toxicology (Bingham, E., Cohrssen, B., and Powell, C. H., Eds.) pp 969-1105, Wiley, New York.
2. Talaska, G. (2003) Aromatic amines and human urinary bladder cancer: exposure sources and epidemiology. J. Environ. Sci. Health, Part C: Environ. Carcinog. Ecotoxicol. Rev. 21, 29-43.
3. Vineis, P., and Pirastu, R. (1997) Aromatic amines and cancer. Cancer Causes Control 8, 346-355.
4. Markowitz, S. B., and Levin, K. (2004) Continued epidemic of bladder cancer in workers exposed to orthno-toluidine in a chemical factory. J. Occup. Environ. Med. 46, 154-160.
5. Gan, J., Skipper, P. L., Gago-Dominguez, M., Arakawa, K., Ross, R. K., Yu, M. C., and Tannenbaum, S. R. (2004) Alkylaniline-hemoglobin adducts and risk of non-smoking-related bladder cancer. J. Natl. Cancer Inst. 96, 1425-1431.
6. U. S. National Toxicology Program (1990) Toxicology and Carcinogenesis Studies of 2,6-Xylidine (2,6-Dimethylaniline) (CAS No. 87-62-7) in Charles River CD Rats (Feed Studies). Technical Report Series No. 278, NTP, Research Triangle Park, NC.
7. 14C]-2,6-dimethylaniline to DNA of rat liver and ethmoid turbinate. J. Toxicol. Environ. Health 27, 85-94.
8. Marques, M. M., Mourato, L. L. G., Amorim, M. T., Santos, M. A., Melchior, Jr., W. B., and Beland, F. A. (1997) Effect of substitution site upon the oxidation potentials of alkylanilines, the mutagenicities of N-hydroxyalkylanilines, and the conformations of alkylaniline-DNA adducts. Chem. Res. Toxicol. 10, 1266-1274.
9. 32P-postlabeling efficiencies of 2,6-dimethylaniline-DNA adducts. Chem. Res. Toxicol. 14, 165-174.
10. Brown, K., Tompkins, E. M., and White, I. N. H. (2006) Applications of accelerator mass spectrometry for pharmacological and toxicological research. Mass Spectrom. Rev. 25, 127-145.
11. 14C in nonvolatile samples by accelerator mass spectrometry. Anal. Chem. 76, 328-334.
12. Chaudhury, C., Mehnaz, S., Robinson, J. M., Hayton, W. L., Pearl, D. K., Roopenian, D. C., and Anderson, C. L. (2003) The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan. J. Exp. Med. 197, 315-322.
13. Lutz, W. K. (1979) In vivo covalent binding of organic chemicals as a quantitative indicator in the process of chemical carcinogenesis. Mutat. Res. 65, 289-356.
14. Sabbioni, G. (1992) Hemoglobin binding of monocyclic aromatic amines: molecular dosimetry and quantitative structure activity relationships for the N-oxidation. Chem.-Biol. Interact. 81, 91-117.
15. National Institute for Occupational Safety and Health (1991) Interim report No. 2, HETA 88-159, Goodyear Tire and Rubber Co. Niagara Falls, N. Y., NIOSH, Cincinnati, OH.
16. Murphy, S. E., Palomino, A., Hecht, S. S., and Hoffmann, D. (1990) Dose-response study of DNA and hemoglobin adduct formation by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats. Cancer Res. 50, 5446-5452.